Avodart capsules 0.5 mg are used for the treatment of benign prostatic hyperplasia.
Active ingredient – Dutasteride 0.5 mg (per capsule)
Used for the treatment of benign prostatic hyperplasia (BPH) — to reduce the size of the enlarged prostate, improve urinary flow, and lower the risk of acute urinary retention and the need for surgical intervention.
The recommended dose for adult men (including elderly patients) is 0.5 mg (1 capsule) once daily.
The capsule should be swallowed whole, without chewing or opening.
Food does not affect the absorption of the drug.
Although some improvement may be noticed early, treatment should be continued for at least 6 months to accurately assess its effectiveness.
No dose adjustment is necessary in patients with renal impairment (as less than 0.1% of the drug is excreted in the urine).
Use with caution in patients with hepatic impairment, as dutasteride undergoes extensive liver metabolism and has a half-life of approximately 3 to 5 days.
Reproductive system:
Erectile dysfunction
Decreased libido
Ejaculation disorders
Gynecomastia (breast enlargement or tenderness in men)
Allergic reactions:
In rare cases: rash, urticaria (hives), localized swelling
Hypersensitivity to dutasteride or any of the excipients
Hypersensitivity to other 5-alpha reductase inhibitors
Contraindicated in women and children